Failed anxiety drug may help stuttering
Published: Dec. 31, 2005 at 6:48 PM
LEXINGTON, Mass., Dec. 31 (UPI) -- A Lexington, Mass., drug company is conducting a clinical trial of a drug that may help those who stutter.
Indevus Pharmaceuticals Inc. has enrolled about half of the 120 patients they hope to include in the clinical trial. The drug company said it expects results by the middle of 2006 and if successful, a larger trial would follow, reported the Boston Globe Saturday.
Pagoclone, the experimental drug from Indevus, was a potential psychiatric drug when discovered in the 1990s. After it was licensed, drug giant Pfizer Inc. found it did not show clear improvement for panic and anxiety -- but two women who had used it stopped stuttering.
Indevus officials re-acquired the rights to pagoclone, took out a fresh patent and began the new clinical trial.
Indevus Pharmaceuticals Inc. has enrolled about half of the 120 patients they hope to include in the clinical trial. The drug company said it expects results by the middle of 2006 and if successful, a larger trial would follow, reported the Boston Globe Saturday.
Pagoclone, the experimental drug from Indevus, was a potential psychiatric drug when discovered in the 1990s. After it was licensed, drug giant Pfizer Inc. found it did not show clear improvement for panic and anxiety -- but two women who had used it stopped stuttering.
Indevus officials re-acquired the rights to pagoclone, took out a fresh patent and began the new clinical trial.
© 2005 United Press International. All Rights Reserved.
This material may not be reproduced, redistributed, or manipulated in any form.
This material may not be reproduced, redistributed, or manipulated in any form.
» Next in Business:
Surgeon general advises parents on teens
Latest Headlines
- Canadian autoworkers reach labor deals
- Groups sue to stop Texas border fence
- Back injury sidelines Serena Williams
- GM reaches pact with union in Delta strike
- Calif. wine pioneer Mondavi dies
- Stroke outcome helped by clot-busting drug
- Study casts doubt on high-salt diet risk
- Huckabee jokes about Obama gunman
Most Popular
- Huckabee jokes about Obama gunman
- Study: Fish underwent 'reverse evolution'
- Back injury sidelines Serena Williams
- Flights at N.Y.-area airports to be capped
- Senator: McCain's military roots limit him
- Study casts doubt on high-salt diet risk
- Calif. wine pioneer Mondavi dies
- GM reaches pact with union in Delta strike